UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.097

Sortiert nach

Total neoadjuvant therapy for rectal cancer: An emerging option

Cancer, 2017-05, Vol.123 (9), p.1497-1506

2017

Volltextzugriff (PDF)

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

Journal of clinical oncology, 2012-12, Vol.30 (35), p.4344-4351

2012

Volltextzugriff (PDF)

RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal

International journal of radiation oncology, biology, physics, 2013-05, Vol.86 (1), p.27-33

2013

Volltextzugriff (PDF)

Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas

International journal of radiation oncology, biology, physics, 2009-07, Vol.74 (3), p.824-830

2009

Volltextzugriff (PDF)

Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases

JNCI : Journal of the National Cancer Institute, 2015-09, Vol.107 (9), p.1

2015

Volltextzugriff (PDF)

Biomarkers of response and resistance to antiangiogenic therapy

Nature reviews. Clinical oncology, 2009-06, Vol.6 (6), p.327-338

2009

Volltextzugriff (PDF)

Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

Journal of clinical oncology, 2009-06, Vol.27 (18), p.3020-3026

2009

Volltextzugriff (PDF)

Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704

Journal of clinical oncology, 2008-12, Vol.26 (36), p.5918-5922

2008

Volltextzugriff (PDF)

Long-Term Results of RTOG Trial 8911 (USA Intergroup 113): A Random Assignment Trial Comparison of Chemotherapy Followed by Surgery Compared With Surgery Alone for Esophageal Cancer

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3719-3725

2007

Volltextzugriff (PDF)

Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas

International journal of radiation oncology, biology, physics, 2012-02, Vol.82 (2), p.809-816

2012

Volltextzugriff (PDF)

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Nature medicine, 2004-02, Vol.10 (2), p.145-147

2004

Volltextzugriff (PDF)

Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for Solid Cancers

Journal of clinical oncology, 2007-09, Vol.25 (26), p.4033-4042

2007

Volltextzugriff (PDF)

Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant Gliomas

International journal of radiation oncology, biology, physics, 2012-04, Vol.82 (5), p.2018-2024

2012

Volltextzugriff (PDF)

Locally Advanced Pancreatic Cancer

Journal of clinical oncology, 2005-07, Vol.23 (20), p.4538-4544

2005

Volltextzugriff (PDF)

The correlation between internal and external markers for abdominal tumors: Implications for respiratory gating

International journal of radiation oncology, biology, physics, 2005-04, Vol.61 (5), p.1551-1558

2005

Volltextzugriff (PDF)

Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial

International journal of radiation oncology, biology, physics, 2013-11, Vol.87 (4), p.638-645

2013

Volltextzugriff (PDF)

Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma

International journal of radiation oncology, biology, physics, 2009-01, Vol.73 (1), p.148-153

2009

Volltextzugriff (PDF)

Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4096-4102

2009

Volltextzugriff (PDF)

The Influence of Total Nodes Examined, Number of Positive Nodes, and Lymph Node Ratio on Survival After Surgical Resection and Adjuvant Chemoradiation for Pancreatic Cancer: A Secondary Analysis of RTOG 9704

International journal of radiation oncology, biology, physics, 2011-12, Vol.81 (5), p.1328-1335

2011

Volltextzugriff (PDF)

Impact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer A Pooled Analysis

Journal of clinical oncology, 2004-05, Vol.22 (10), p.1785-1796

2004

Volltextzugriff (PDF)

Intraoperative Radiation Therapy

Journal of clinical oncology, 2007-03, Vol.25 (8), p.971-977

2007

Volltextzugriff (PDF)

Promotion of Smoking Cessation with Emotional and/or Graphic Antismoking Advertising

American journal of preventive medicine, 2012-11, Vol.43 (5), p.475-482

2012

Volltextzugriff (PDF)

Fluence Map Prediction Using Deep Learning Models - Direct Plan Generation for Pancreas Stereotactic Body Radiation Therapy

Frontiers in artificial intelligence, 2020-09, Vol.3, p.68-68

2020

Volltextzugriff (PDF)

VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects

Trends in molecular medicine, 2007-06, Vol.13 (6), p.223-230

2007

Volltextzugriff (PDF)

A Phase II Study of a Paclitaxel-Based Chemoradiation Regimen With Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246

International journal of radiation oncology, biology, physics, 2012-04, Vol.82 (5), p.1967-1972

2012

Volltextzugriff (PDF)

1 – 25 von 2.097

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.800)
Mit Volltextzugriff
(1.777)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.392)
Life Sciences & Biomedicine
(1.038)
Humans
(1.007)
Female
(714)
Biological And Medical Sciences
(635)
Middle Aged
(610)
Medical Sciences
(592)
Adult
(582)
Risk Factors
(436)
Male
(411)
Oncology
(385)
Prospective Studies
(373)
Aged
(348)
Tumors
(244)
Cohort Studies
(243)
Physical Sciences
(222)
Technology
(202)
Surveys And Questionnaires
(198)
Public, Environmental & Occupational Health
(186)
General & Internal Medicine
(175)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Total neoadjuvant therapy for rectal cancer: An emerging option

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal

Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas

Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases

Biomarkers of response and resistance to antiangiogenic therapy

Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704

Long-Term Results of RTOG Trial 8911 (USA Intergroup 113): A Random Assignment Trial Comparison of Chemotherapy Followed by Surgery Compared With Surgery Alone for Esophageal Cancer

Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for Solid Cancers

Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant Gliomas

Locally Advanced Pancreatic Cancer

The correlation between internal and external markers for abdominal tumors: Implications for respiratory gating

Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial

Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma

Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411

The Influence of Total Nodes Examined, Number of Positive Nodes, and Lymph Node Ratio on Survival After Surgical Resection and Adjuvant Chemoradiation for Pancreatic Cancer: A Secondary Analysis of RTOG 9704

Impact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer A Pooled Analysis

Intraoperative Radiation Therapy

Promotion of Smoking Cessation with Emotional and/or Graphic Antismoking Advertising

Fluence Map Prediction Using Deep Learning Models - Direct Plan Generation for Pancreas Stereotactic Body Radiation Therapy

VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects

A Phase II Study of a Paclitaxel-Based Chemoradiation Regimen With Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246

Suchergebnisse filtern